Top analysts on stock perps · Analyst
Ilya Zubkov (Freedom Capital Markets): analyst track record on stock perps
Ilya Zubkov of Freedom Capital Markets on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars2.7★
Success55%
Excess return+5.3%
rank#5,729
Ratings20
ratings on stock perps10
Track record
TipRanks dataAfter buy calls: not enough measured cases yet
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $MRK Merck & Co., Inc. | Hold · Maintained | $140 | -6.4% | Nov 2, 2026 |
| $ALNY Alnylam Pharmaceuticals, Inc. | Buy · Maintained | $350 | +112.1% | Oct 30, 2026 |
| $LLY Eli Lilly and Company | Buy · Maintained | $1,600 | +12.9% | Oct 30, 2026 |
| $BIIB Biogen Inc. | Buy · Maintained | $275 | +10.6% | Oct 29, 2026 |
| $ILMN Illumina, Inc. | Hold · Downgraded | $185 | -18.8% | Aug 5, 2026 |
| $JNJ Johnson & Johnson | Buy · Upgraded | $280 | +2.5% | Jul 16, 2026 |
| $AMGN Amgen Inc. | Buy · Upgraded | $375 | -19.7% | May 7, 2026 |
Recent ratings
- Nov 2, 2026 $MRK: Maintained · Hold · $140 · article
- Oct 30, 2026 $LLY: Maintained · Buy · $1,600 · article
- Oct 30, 2026 $LLY: Maintained · Buy · $1,600 · article
- Oct 30, 2026 $ALNY: Maintained · Buy · $350 · article
- Oct 30, 2026 $ALNY: Maintained · Buy · $350 · article
- Oct 29, 2026 $BIIB: Maintained · Buy · $275 · article
- Aug 5, 2026 $ILMN: Downgraded · Hold · $185 · article
- Jul 16, 2026 $JNJ: Upgraded · Buy · $280 · article
- May 7, 2026 $AMGN: Upgraded · Buy · $375 · article
- May 1, 2026 $BIIB: Upgraded · Buy · $245 · article
Ilya Zubkov2.7★ · 55% success · +5.3% excess return · TipRanks data · Source headlines via TheFly/StreetInsider. Reaction = venue-median perp move after our detection — an observation, not investment advice.